| Date Filed | Type | Description |
| 08/16/2023 |
4
| Donenberg Phillip B. (Director) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 111,111 shares
@ $0.9, valued at
$100k
|
|
| 06/08/2023 |
4
| Donenberg Phillip B. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,643 options to buy
@ $1.09, valued at
$19.2k
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Donenberg Phillip B. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,478 options to buy
@ $1.06, valued at
$18.5k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Donenberg Phillip B. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,438 options to buy
@ $9.63, valued at
$167.9k
|
|
| 02/18/2021 |
4
| Donenberg Phillip B. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Bought 2,000 shares
@ $11.71, valued at
$23.4k
|
|
| 09/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/05/2020 |
4
| Donenberg Phillip B. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 14,000 options to buy
@ $21.91, valued at
$306.7k
|
|
| 06/13/2019 |
4
| Donenberg Phillip B. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 9,675 options to buy
@ $13.6, valued at
$131.6k
|
|
| 07/16/2018 |
4
| Donenberg Phillip B. (SVP and CFO) has filed a Form 4 on DEPOMED INC|
Txns:
| Granted 87,163 restricted stock units
@ $0 |
|
| 07/16/2018 |
3
| Donenberg Phillip B. (SVP and CFO) has filed a Form 3 on DEPOMED INC |
| 06/22/2018 |
4
| Donenberg Phillip B. (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 18,743 options to buy
@ $19, valued at
$356.1k
|
|
| 06/20/2018 |
3
| Donenberg Phillip B. (Director) has filed a Form 3 on AVROBIO, Inc. |
| 05/15/2018 |
4
| Donenberg Phillip B. (CFO) has filed a Form 4 on AveXis, Inc.|
Txns:
| Disposed/sold 3,800 shares
@ $0
Disposed/sold 20,000 options to buy
@ $37.58, valued at
$751.6k
Disposed/sold 5,594 options to buy
@ $77.24, valued at
$432.1k
Disposed/sold 4,406 options to buy
@ $88.08, valued at
$388.1k
Disposed/sold 10,000 options to buy
@ $100.52, valued at
$1M
Disposed/sold 15,000 options to buy
@ $133.8, valued at
$2M
|
|
| 03/27/2018 |
4
| Donenberg Phillip B. (CFO) has filed a Form 4 on AveXis, Inc.|
Txns:
| Granted 3,800 shares
@ $0
Granted 15,000 options to buy
@ $133.8, valued at
$2M
|
|
| 10/20/2017 |
4
| Donenberg Phillip B. (CFO) has filed a Form 4 on AveXis, Inc.|
Txns:
| Granted 10,000 options to buy
@ $100.52, valued at
$1M
|
|
| 10/20/2017 |
3
| Donenberg Phillip B. (CFO) has filed a Form 3 on AveXis, Inc. |
| 07/29/2014 |
4
| DONENBERG PHILIP B (Director) has filed a Form 4 on RestorGenex Corp|
Txns:
| Granted 271,475 options to buy
@ $3.92, valued at
$1.1M
|
|
| 06/06/2014 |
4
| DONENBERG PHILIP B (CFO) has filed a Form 4 on RestorGenex Corp|
Txns:
| Granted 250,000 options to buy
@ $4, valued at
$1M
|
|
| 01/27/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/08/2011 |
4
| DONENBERG PHILIP B (Sr. VP of Finance, CFO & Secy) has filed a Form 4 on BIOSANTE PHARMACEUTICALS INC|
Txns:
| Bought 1,000 shares
@ $2.19, valued at
$2.2k
|
|
| 01/21/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/20/2011 |
4
| DONENBERG PHILIP B (Sr. VP of Finance, CFO & Sec'y) has filed a Form 4 on BIOSANTE PHARMACEUTICALS INC|
Txns:
| Bought 1,000 shares
@ $1.8799, valued at
$1.9k
|
|
| 02/03/2010 |
4
| DONENBERG PHILIP B (CFO, Treasurer and Secretary) has filed a Form 4 on BIOSANTE PHARMACEUTICALS INC|
Txns:
| Granted 100,000 options to buy
@ $1.54, valued at
$154k
|
|
| 02/02/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 01/05/2009 |
4
| DONENBERG PHILIP B (CFO, Treasurer and Secretary) has filed a Form 4 on BIOSANTE PHARMACEUTICALS INC |